首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 基因療法

市場調查報告書

商品編碼

1890928

基因載體市場：按載體類型、有效載荷類型、應用、疾病領域、遞送途徑、遞送方式、最終用戶和地區分類

Gene Vector Market, By Vector Type, By Payload Type, By Application, By Disease Area, By Delivery Route, By Delivery Mode, By End User, By Geography

出版日期: 2025年11月18日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

基因載體市場預計在 2025 年達到 93.5 億美元，預計到 2032 年將達到 215.9 億美元，2025 年至 2032 年的複合年成長率為 12.7%。

報告內容		報告詳情
基準年：	2024	2025年市場規模：	93.5億美元
歷史數據時期：	2020年至2024年	預測期：	2025年至2032年
預測期（2025-2032年）複合年成長率：	12.70%	2032 年的預測值：	215.9億美元

全球基因載體市場是生物技術和製藥行業的重要組成部分，涵蓋了旨在將治療性遺傳物質輸送到目標細胞以治療各種疾病的先進遞送系統。基因載體作為載體，將包括DNA、RNA和其他核酸在內的遺傳物質導入患者細胞，使其能夠糾正遺傳缺陷、增強免疫反應或遞送治療性蛋白質。

該市場涵蓋多種載體類型，包括病毒載體（腺病毒、慢病毒、逆轉錄病毒、腺結合病毒）、非病毒載體（脂質體轉染、電穿孔、顯微注射）以及新興的混合系統。遺傳性疾病、癌症和罕見疾病的日益普遍顯著增加了對創新基因治療解決方案的需求，使基因載體成為個人化醫療方法中的關鍵組成部分。

由於基因治療研究投入的增加、基因治療監管核准的推進以及載體工程技術的進步，市場正經歷顯著成長。領先的製藥公司、生技公司和研究機構正積極致力於開發新型載體系統，以提高遞送效率、降低免疫抗原性並增強治療效果，從而擴大腫瘤學、眼科學、免疫學和罕見疾病治療領域的市場潛力。

市場動態

全球基因載體市場受多種主要因素驅動，其中包括遺傳性疾病和癌症發病率的不斷上升，這迫切需要創新療法，而基因載體恰好能夠提供這種療法。對基因治療研發的大量投資，以及政府資金和創業投資的不斷增加，都在推動市場成長。

基因治療臨床試驗數量的增加以及近期監管部門的核准，包括美國FDA核准的多種基因治療產品，為市場創造了有利條件。載體工程技術的進步，例如靶向特異性的提高和免疫抗原性的降低，正在提升治療效果和患者安全性。然而，市場也面臨許多限制因素，主要在於基因載體的研發和生產高成本，這限制了其普及性和商業性可行性。

複雜的監管要求和漫長的核准流程阻礙了市場准入和產品商業化。病毒載體誘導的免疫反應、潛在的插入突變以及長期影響等安全隱患仍然是市場接受度的障礙。此外，載體設計方面的技術挑戰，例如有效載荷能力有限和組織特異性標靶化困難，也限制了其治療應用。然而，市場格局仍蘊藏著巨大的機會。

基因載體在治療治療選擇有限的罕見疾病領域的應用日益廣泛，展現出盈利的成長潛力。亞太和拉丁美洲等新興市場醫療基礎設施的改善和公眾意識的提高，正在釋放這些地區尚未開發的潛力。製藥公司和生物技術公司之間的夥伴關係正在推動創新和市場擴張。新一代載體的研發，憑藉其更高的安全性、更強的遞送能力以及有望降低生產成本的生產技術進步，為市場參與企業帶來了顯著的成長機會。

本次調查的主要特點

本報告對全球基因載體市場進行了詳細分析，以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和復合年成長率（%）。
該報告重點介紹了各個細分市場的潛在商機，並為該市場說明了一個有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
該報告根據以下參數對全球基因載體市場的主要企業進行了分析：公司概況、產品系列、主要特徵、財務績效和策略。
本報告的研究結果將使負責人和企業經營團隊能夠就即將推出的產品、類型升級、市場擴張和行銷策略做出明智的決策。
這份全球基因載體市場報告針對該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種用於分析全球基因載體市場的策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第12章競爭格局

Lonza Group
Thermo Fisher Scientific
Catalent Inc
Oxford Biomedica
FUJIFILM Diosynth Biotechnologies
Advanced Therapies, LLC.
Aldevron
AGC Biologics
SIRION Biotech
FinVector
Merck KGaA
uniQure
Charles River Laboratories
Takara Bio

第13章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第14章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI8956

Gene Vector Market is estimated to be valued at USD 9.35 Bn in 2025 and is expected to reach USD 21.59 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 9.35 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.70%	2032 Value Projection:	USD 21.59 Bn

The global gene vector market represents a pivotal segment within the biotechnology and pharmaceutical industries, encompassing sophisticated delivery systems designed to transport therapeutic genetic material into target cells for treatment of various diseases. Gene vectors serve as vehicles that facilitate the introduction of genetic material, including DNA, RNA, and other nucleic acids, into patient cells to correct genetic defects, enhance immune responses, or provide therapeutic proteins.

This market encompasses various vector types including viral vectors (adenovirus, lentivirus, retrovirus, adeno-associated virus), non-viral vectors (lipofection, electroporation, microinjection), and emerging hybrid systems. The growing prevalence of genetic disorders, cancer, and rare diseases has significantly amplified the demand for innovative gene therapy solutions, positioning gene vectors as critical components in personalized medicine approaches.

The market has witnessed substantial growth driven by increasing investments in gene therapy research, regulatory approvals for gene-based treatments, and technological advancements in vector engineering. Major pharmaceutical companies, biotechnology firms, and research institutions are actively developing novel vector systems to improve delivery efficiency, reduce immunogenicity, and enhance therapeutic outcomes, thereby expanding the market's potential across oncology, ophthalmology, immunology, and rare disease applications.

Market Dynamics

The global gene vector market is propelled by several key drivers, including the rising incidence of genetic disorders and cancer worldwide, which necessitates innovative therapeutic approaches that gene vectors can provide. Substantial investments in gene therapy research and development, coupled with increasing government funding and venture capital investments, are accelerating market growth.

The growing number of clinical trials for gene therapies and recent regulatory approvals, such as U.S. FDA approvals for various gene therapy products, have created favorable market conditions. Technological advancements in vector engineering, including improved targeting specificity and reduced immunogenicity, are enhancing therapeutic efficacy and patient safety profiles. However, the market faces significant restraints, primarily the high costs associated with gene vector development and manufacturing, which limit accessibility and commercial viability.

Complex regulatory requirements and lengthy approval processes create barriers for market entry and product commercialization. Safety concerns related to viral vector-induced immune responses, potential insertional mutagenesis, and long-term effects continue to challenge market acceptance. Additionally, technical challenges in vector design, including limited payload capacity and tissue-specific targeting difficulties, restrict therapeutic applications. Nevertheless, substantial opportunities exist within the market landscape.

The expanding applications of gene vectors in treating rare diseases, where limited therapeutic options exist, present lucrative growth prospects. Emerging markets in Asia Pacific and Latin America offer untapped potential due to improving healthcare infrastructure and increasing awareness. Collaborative partnerships between pharmaceutical companies and biotechnology firms are fostering innovation and market expansion. The development of next-generation vectors with improved safety profiles and enhanced delivery capabilities, along with advances in manufacturing technologies that could reduce production costs, represent significant growth opportunities for market participants.

Key Features of the Study

This report provides in-depth analysis of the global gene vector market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gene vector market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Lonza Group, Thermo Fisher Scientific, Catalent Inc, Oxford Biomedica, FUJIFILM Diosynth Biotechnologies, Advanced Therapies, LLC., Aldevron, AGC Biologics, SIRION Biotech, FinVector, Merck KGaA, uniQure, Charles River Laboratories, Takara Bio.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global gene vector market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene vector market

Market Segmentation

Vector Type Insights (Revenue, USD Bn, 2020 - 2032)
- Viral Vectors
- Adenoviral Vectors
- Adeno-Associated Viral (AAV) Vectors
- Lentiviral Vectors
- Gamma-Retroviral Vectors
- Herpes Simplex Viral (HSV) Vectors
- Poxviral/Vaccinia Vectors
- Other Viral Vectors (Sendai, VSV, Baculovirus, etc.)
- Non-Viral Vectors
- Plasmid DNA Vectors
- Lipid-Based Nanoparticle (LNP) Vectors
- Polymeric/Synthetic Nanoparticle Vectors
- Inorganic Nanoparticle Vectors (gold, silica-based, etc.)
Payload Type Insights (Revenue, USD Bn, 2020 - 2032)
- DNA Vectors
- RNA Vectors
- siRNA/shRNA Vectors
- CRISPR/Cas Components
- Antisense Oligonucleotides
- mRNA Vectors
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Gene Replacement Therapy
- Gene Addition/Augmentation Therapy
- Gene Silencing/Knockdown
- Gene Editing (CRISPR, ZFN, TALEN)
- Cell Therapy Manufacturing (CAR-T, engineered NK/T cells)
- Vaccines (prophylactic and therapeutic)
- Research Use Only (preclinical in vitro/in vivo tools)
Disease Area Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Neurology
- Cardiovascular and Metabolic
- Ophthalmic
- Hematologic and Immunologic
- Infectious Diseases
- Musculoskeletal and Genetic Muscle Disorders
- Dermatology and Wound Healing
- Other Rare Genetic Disorders
Delivery Route Insights (Revenue, USD Bn, 2020 - 2032)
- Intravenous
- Intramuscular
- Subcutaneous
- Intrathecal
- Intratumoral
- Ocular
- Inhalation
- Others
Delivery Mode Insights (Revenue, USD Bn, 2020 - 2032)
- In Vivo Delivery
- Ex Vivo Delivery
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Biopharmaceutical and Biotechnology Companies
- CDMOs/CMOs (Contract Development and Manufacturing Organizations)
- Academic and Research Institutes
- Government and Non-Profit Research Organizations
- Hospital-Based and Specialty Gene Therapy Centers
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Lonza Group
- Thermo Fisher Scientific
- Catalent Inc
- Oxford Biomedica
- FUJIFILM Diosynth Biotechnologies
- Advanced Therapies, LLC.
- Aldevron
- AGC Biologics
- SIRION Biotech
- FinVector
- Merck KGaA
- uniQure
- Charles River Laboratories
- Takara Bio

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Gene Vector Market, By Vector Type
- Global Gene Vector Market, By Payload Type
- Global Gene Vector Market, By Application
- Global Gene Vector Market, By Disease Area
- Global Gene Vector Market, By Delivery Route
- Global Gene Vector Market, By Delivery Mode
- Global Gene Vector Market, By End User
- Global Gene Vector Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Gene Vector Market, By Vector Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Viral Vectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Adenoviral Vectors
  - Adeno-Associated Viral (AAV) Vectors
  - Lentiviral Vectors
  - Gamma-Retroviral Vectors
  - Herpes Simplex Viral (HSV) Vectors
  - Poxviral/Vaccinia Vectors
  - Other Viral Vectors (Sendai, VSV, Baculovirus, etc.)
Non-Viral Vectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Plasmid DNA Vectors
  - Lipid-Based Nanoparticle (LNP) Vectors
  - Polymeric/Synthetic Nanoparticle Vectors
  - Inorganic Nanoparticle Vectors (gold, silica-based, etc.)

5. Global Gene Vector Market, By Payload Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
DNA Vectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
RNA Vectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
siRNA/shRNA Vectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
CRISPR/Cas Components
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antisense Oligonucleotides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
mRNA Vectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Gene Vector Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Gene Replacement Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gene Addition/Augmentation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gene Silencing/Knockdown
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gene Editing (CRISPR, ZFN, TALEN)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cell Therapy Manufacturing (CAR-T, engineered NK/T cells)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Vaccines (prophylactic and therapeutic)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Use Only (preclinical in vitro/in vivo tools)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Gene Vector Market, By Disease Area, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiovascular and Metabolic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ophthalmic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hematologic and Immunologic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Musculoskeletal and Genetic Muscle Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dermatology and Wound Healing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Rare Genetic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Gene Vector Market, By Delivery Route, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intrathecal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intratumoral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ocular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Gene Vector Market, By Delivery Mode, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
In Vivo Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ex Vivo Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Gene Vector Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
CDMOs/CMOs (Contract Development and Manufacturing Organizations)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Government and Non-Profit Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hospital-Based and Specialty Gene Therapy Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Gene Vector Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Vector Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Payload Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Area, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Route, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive Landscape

Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Catalent Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Oxford Biomedica
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
FUJIFILM Diosynth Biotechnologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Advanced Therapies, LLC.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aldevron
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AGC Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SIRION Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
FinVector
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
uniQure
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

13. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

14. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

基因載體市場規模、佔有率和趨勢分析報告：按類型、遞送方式、治療領域、最終用途、地區和細分市場預測（2025-2033 年）

FAQ

基因載體市場：按載體類型、有效載荷類型、應用、疾病領域、遞送途徑、遞送方式、最終用戶和地區分類

Gene Vector Market, By Vector Type, By Payload Type, By Application, By Disease Area, By Delivery Route, By Delivery Mode, By End User, By Geography

市場動態

目錄

第1章研究目標與前提條件

第2章市場範圍

第3章市場動態、監理及趨勢分析

4. 2020-2032年全球基因載體市場（依載體類型分類）

5. 2020-2032年全球基因載體市場（依酬載類型分類）

6. 2020-2032年全球基因載體市場（依應用領域分類）

7. 2020-2032年全球基因載體市場（依治療領域分類）

8. 2020-2032年全球基因載體市場（依遞送途徑分類）

9. 2020-2032年全球基因載體市場（以遞送方式分類）

10. 2020-2032年全球基因載體市場（依最終用戶分類）

11. 2020-2032年全球基因載體市場（按地區分類）

第12章競爭格局

第13章分析師建議

第14章參考文獻與調查方法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Gene Vector Market, By Vector Type, 2020-2032, (USD Bn)

5. Global Gene Vector Market, By Payload Type, 2020-2032, (USD Bn)

6. Global Gene Vector Market, By Application, 2020-2032, (USD Bn)

7. Global Gene Vector Market, By Disease Area, 2020-2032, (USD Bn)

8. Global Gene Vector Market, By Delivery Route, 2020-2032, (USD Bn)

9. Global Gene Vector Market, By Delivery Mode, 2020-2032, (USD Bn)

10. Global Gene Vector Market, By End User, 2020-2032, (USD Bn)

11. Global Gene Vector Market, By Region, 2020 - 2032, Value (USD Bn)

12. Competitive Landscape

13. Analyst Recommendations

14. References and Research Methodology

基因載體市場：按載體類型、有效載荷類型、應用、疾病領域、遞送途徑、遞送方式、最終用戶和地區分類

Gene Vector Market, By Vector Type, By Payload Type, By Application, By Disease Area, By Delivery Route, By Delivery Mode, By End User, By Geography

市場動態

目錄

第1章 研究目標與前提條件

第2章 市場範圍

第3章 市場動態、監理及趨勢分析

4. 2020-2032年全球基因載體市場（依載體類型分類）

5. 2020-2032年全球基因載體市場（依酬載類型分類）

6. 2020-2032年全球基因載體市場（依應用領域分類）

7. 2020-2032年全球基因載體市場（依治療領域分類）

8. 2020-2032年全球基因載體市場（依遞送途徑分類）

9. 2020-2032年全球基因載體市場（以遞送方式分類）

10. 2020-2032年全球基因載體市場（依最終用戶分類）

11. 2020-2032年全球基因載體市場（按地區分類）

第12章 競爭格局

第13章 分析師建議

第14章 參考文獻與調查方法

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Gene Vector Market, By Vector Type, 2020-2032, (USD Bn)

5. Global Gene Vector Market, By Payload Type, 2020-2032, (USD Bn)

6. Global Gene Vector Market, By Application, 2020-2032, (USD Bn)

7. Global Gene Vector Market, By Disease Area, 2020-2032, (USD Bn)

8. Global Gene Vector Market, By Delivery Route, 2020-2032, (USD Bn)

9. Global Gene Vector Market, By Delivery Mode, 2020-2032, (USD Bn)

10. Global Gene Vector Market, By End User, 2020-2032, (USD Bn)

11. Global Gene Vector Market, By Region, 2020 - 2032, Value (USD Bn)

12. Competitive Landscape

13. Analyst Recommendations

14. References and Research Methodology

第1章研究目標與前提條件

第2章市場範圍

第3章市場動態、監理及趨勢分析

第12章競爭格局

第13章分析師建議

第14章參考文獻與調查方法